Bayer submits application in EU for extension of finerenone to include early stages of CKD associated with type-II diabetes Read more
Enhertu improves both progression-free and overall survival in Destiny-Breast04 trial in patients with HER2-low metastatic breast cancer Read more
Roche’s Faricimab improves and maintains vision in two leading causes of vision loss: Lancet Read more